JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C200533200 on October 31, 2002

J. Biol. Chem., Vol. 277, Issue 51, 49101-49104, December 20, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/51/49101    most recent
C200533200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tcherpakov, M.
Right arrow Articles by Fainzilber, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tcherpakov, M.
Right arrow Articles by Fainzilber, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ACCELERATED PUBLICATION
The p75 Neurotrophin Receptor Interacts with Multiple MAGE Proteins*

Marianna TcherpakovDagger , Francisca C. BronfmanDagger , Silvestro G. ConticelloDagger , Anna VaskovskyDagger , Zehava LevyDagger , Michio Niinobe§, Kazuaki Yoshikawa§, Ernest Arenas, and Mike FainzilberDagger ||

From the Dagger  Molecular Neurobiology Group, Department of Biological Chemistry, Weizmann Institute of Science, 76100 Rehovot, Israel, the § Division of Regulation of Macromolecular Functions, Institute for Protein Research, Osaka University, Osaka 565-0871, Japan, and the  Department of Medical Biochemistry and Biophysics, Karolinska Institute, S-17177 Stockholm, Sweden

Received for publication, September 19, 2002, and in revised form, October 21, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The p75 neurotrophin receptor has been implicated in diverse aspects of neurotrophin signaling, but the mechanisms by which its effects are mediated are not well understood. Here we identify two MAGE proteins, necdin and MAGE-H1, as interactors for the intracellular domain of p75 and show that the interaction is enhanced by ligand stimulation. PC12 cells transfected with necdin or MAGE-H1 exhibit accelerated differentiation in response to nerve growth factor. Expression of these two MAGE proteins is predominantly cytoplasmic in PC12 cells, and necdin was found to be capable of homodimerization, suggesting that it may act as a cytoplasmic adaptor to recruit a signaling complex to p75. These findings indicate that diverse MAGE family members can interact with the p75 receptor and highlight type II MAGE proteins as a potential family of interactors for signaling proteins containing type II death domains.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Neuronal responses to activation of the p75 neurotrophin receptor range from enhanced outgrowth to increased cell death, and p75 null mice exhibit a plethora of defects in both neuronal and non-neuronal systems (1, 2). However, the primary interactors and signaling mechanisms activated by p75 are not well understood (3). Although p75 belongs to the TNF receptor superfamily, its intracellular type II death domain does not self-aggregate (4) and does not interact with the major binding partners of type I death domains. Identification of specific signaling partners for p75 has been frustrating, as this particular receptor is a difficult bait in conventional yeast two-hybrid. Nonetheless seven candidate interactors have been reported so far for p75 (3, 5). Most of these candidate interactors lack known catalytic domains, suggesting that they must recruit additional binding partners to form a functional signaling complex. There are no general sequence or functional homologies between the described p75 interactors, and the physiological significance of most of them remains to be established.

To identify biologically relevant interactors for p75, we used the Ras rescue system (RRS)1 for protein interaction trapping in yeast (6). RRS selects for protein interactions in the membrane proximal region of the cytoplasm, and there is no requirement for nuclear or other translocations of the binding partners. The system thus provides an appropriate screening method for the membrane-proximal binding of a receptor intracellular domain with its primary interactors. Our RRS screens identified two MAGE family proteins as novel p75 interactors and highlight type II MAGE proteins as a potential interactor family for type II death domain proteins.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

RRS Screens, cDNA Cloning, and Sequence Analysis-- Plasmids, yeast strains, and screening protocols for RRS were as described (6). Linker (K274RWN to SLPL342) and death domain (T343KRE to ESLC416) regions of p75-ICD were generated by PCR from rat p75. Synthetic oligonucleotides were designed to encode the nine-residue (SESTATSPV) tail domain of p75-ICD. A pADH death domain bait was used to screen a mouse embryonic head cDNA library in pMyr. Alignments of MAGE sequences and phylogenetic trees were constructed using ClustalX.

Expression Analysis-- Rat tissues for Western blot analysis were flash-frozen in liquid nitrogen, macerated to a fine powder, and solubilized in 10 mM Tris, pH 8.0, 150 mM NaCl, 10% glycerol, 1 mM PMSF, 1 mM orthovanadate and proteinase inhibitors (Merck) containing 1% Nonidet P-40. Extracts were separated on SDS-PAGE, blotted, and probed with anti-necdin antibodies.

Cell Culture, Transfections, and Generation of Cell Lines-- PC12 cells were maintained in Dulbecco's modified Eagle's medium containing 6% fetal calf serum and 6% horse serum. For induction of neuronal differentiation, the cells were seeded at a density of 10-15 × 105 cells/cm2 and differentiated for 2-4 days with NGF (5-50 ng/ml). Transient transfection of COS cells was with DEAE-dextran. Transient and stable transfections of PC12 cells lines were carried out by electroporation with 80 µg of DNA per 107 cells in 0.4-cm cuvettes on an ECM-300 (BTX) set to 320 V, 6-ms pulse length. Stably transfected PC12 were selected under 0.5 mg/ml Geneticin for ~4 weeks until resistant colonies appeared.

Immunoprecipitation, Western Blots, and Immunofluorescence-- Cells were lysed in 10 mM Tris, pH8.0, 150 mM NaCl, 10% glycerol, 1 mM PMSF, 1 mM orthovanadate and proteinase inhibitors (Merck) containing either 0.7% CHAPS or 1% Nonidet P-40. Lysates were spun at 10,000 × g for 5 min and then precleared with 30 µl of a 50% suspension of protein-G-Sepharose beads (Amersham Biosciences) before incubation with primary antibody. Immunoprecipitates were eluted with 80 µl of 1 M guanidine HCl in 50 mM Tris, pH 8.0, before running on SDS-PAGE. Primary antibodies for precipitation were as follows: anti-p75 MC192 (from Alomone Laboratories), anti-p75 REX (7), monoclonal anti-HA (from Roche Molecular Biochemicals). Antibodies and dilutions for Western blots were as follows: anti-necdin polyclonal NC243 (8) at 1:5000, anti-necdin polyclonal MNF (9) at 1:1000, anti-HA polyclonal (Santa Cruz) at 1:200, anti-p75 polyclonal 9651 at 1:1000, anti-phospho-cdc2 polyclonal (R & D Systems) at 5 µg/ml, and anti-TrkA RTA (10) at 1:1000. Cells were fixed for immunofluorescence microscopy for 20 min with ice-cold 3% paraformaldehyde in PBS at room temperature, quenched in 0.1 M glycine PBS for 15 min, and permeabilized for 10 min in PBS, 5% donkey serum, 1 mg/ml bovine serum albumin, 0.2% saponin. Permeabilized cells were incubated with anti-HA (1:4000) for 2 h at room temperature followed by donkey anti-rabbit rhodamine-redX-conjugated secondary antibody (1:500, Jackson ImmunoResearch) for 1 h at room temperature.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

A mouse embryonic head RRS library was screened against three baits comprising the death domain, the 69-residue juxtamembrane "linker," and the nine-residue C-terminal "tail" of p75. These screens yielded interacting candidates only for the death domain bait. One of the clones encoded the C-terminal 81 amino acid residues of necdin (11), a MAGE family member thought to act as a cell cycle regulator. Further yeast co-transfections of necdin with the complete panel of p75-ICD subdomains revealed that necdin interacts with both the linker and death domain segments of p75 (Fig. 1A). The sequence homologies between necdin and NRAGE, which was previously identified by Barker and colleagues as a p75 interactor (12), prompted us to examine additional family members. Unfortunately, a number of MAGE constructs (e.g. NRAGE and MAGEL2) were found to associate with yeast plasma membrane, thus precluding their use in the RRS system. MAGE-H1/APR-1 (13) was found to interact robustly with the p75 death domain by RRS (data not shown). Thus, at least three type II MAGE proteins (Fig. 1B) are capable of interacting with p75. Tissue RNA arrays (data not shown) and in silico profiling reveal extensive overlaps in the expression profiles of these genes. Adult rats express robust levels of necdin protein in the hypothalamus and in dorsal root ganglia (DRG) (Fig. 1C), whereas necdin levels during development are much lower.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 1.   Necdin, a MAGE family protein, interacts with p75. A, myristoylated linker and death domain regions of p75 interact with necdin-Ras to rescue transformed yeast grown at 36 °C, whereas no interaction is observed with the tail domain. B, phylogenetic tree showing relationships between human type II MAGE genes; * denotes those shown to interact with p75. C, Western blot analysis of necdin expression in rat tissues. 250 µg of tissue protein was loaded in each lane, and the blot was probed with the anti-necdin MNF antibody. Equal loading was verified by stripping and reprobing the blot with anti-tubulin antibody (not shown).

Co-immunoprecipitation experiments were then carried out in both COS and PC12 cells to confirm the p75-necdin and p75-MAGE-H1 interactions. In accordance with the RRS results, p75 co-precipitated with necdin or MAGE-H1 from transfected COS cells (Fig. 2A) or PC12 cells (Fig. 2B). In PC12 cell lines stably transfected with necdin, application of either NGF or BDNF clearly enhanced the interaction of necdin with p75 (Fig. 2C). Necdin protein levels did not change during the course of this experiment (data not shown). Finally, a p75-necdin interaction at endogenous levels of expression was demonstrated by co-immunoprecipitation from lysates of freshly dissected adult rat DRG (Fig. 2D).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 2.   Association of necdin and MAGE-H1 with p75 in mammalian cells. A, interaction of p75 with MAGE proteins transiently expressed in COS cells. P75 was co-transfected with necdin or MAGE-H1-HA. As a control MAGE proteins were co-transfected with empty vector. Immunoblotting of cell lysates shows equal expression of MAGE proteins with or without p75. P75 was immunoprecipitated with the MC192 antibody and blots were tested for the presence of MAGE proteins with anti-necdin and anti-HA antibodies. MAGE proteins were immunoprecipitated only in the presence of p75. B, interaction of p75 with overexpressed MAGE proteins in transiently transfected PC12 cells. PC12 were electroporated with constructs expressing MAGE proteins, and co-immunoprecipitations were carried out with the indicated antibodies. An irrelevant antibody was used as control (- in the figure). Both necdin and MAGE-H1 were co-precipitated with the p75 antibody, and p75 was co-precipitated with anti-MAGE antibodies. C, interaction of p75 with necdin is enhanced by NGF or BDNF in a stably transfected PC12 line. A stable PC12 cell line expressing HA-necdin was treated with 100 ng/ml NGF or BDNF for 2 h, followed by immunoprecipitation with the MC192 antibody. Western blotting for necdin reveals increasing amounts of co-precipitated necdin upon ligand stimulation. D, co-immunoprecipitation of necdin with p75 from lysates of freshly dissected adult rat DRG. 40-45 DRG were used for each lane, and lysates were precipitated with the anti-p75 monocolonal MC192, followed by Western blot with the anti-necdin polyclonal MNF. E, co-immunoprecipitation of TrkA with p75 from transiently transfected COS cells. NGF (100 ng/ml) was added to the cells 44 h after transfection, and lysates were processed for co-immunoprecipitation after 4 h incubation. P75 pull-down was with the REX antibody, and TrkA detection was with the RTA antibody. F, necdin-necdin interaction exemplified by RRS at 36 °C (left panels) and co-immunoprecipitation from transiently transfected COS cells (right panel).

NRAGE was previously found to affect p75-trk association (12), and we therefore examined whether necdin had similar effects in transiently transfected COS cells stimulated with NGF. TrkA co-precipitated together with p75 in the absence of necdin, and this association was lost in necdin-expressing cells (Fig. 2E). Thus, by interacting with p75, necdin can modulate association of p75 with other neurotrophin receptors.

Necdin, like other MAGE family proteins, does not have any known intrinsic catalytic activity and is likely to signal by recruiting other molecules to a p75 signaling complex. We therefore conducted additional RRS screens using necdin as bait and identified a number of novel expressed sequence tags of unknown function as necdin interactors (data not shown). Interestingly, one known gene obtained in this screen was necdin itself (Fig. 2F, left). Homo-oligomerization of necdin was confirmed by co-immunoprecipitation of differentially tagged necdin proteins from transfected COS cells (Fig. 2F, right).

PC12 cells are a well established model for NGF-induced differentiation and do not express endogenous necdin (14). We therefore examined the influence of transient transfection of necdin or MAGE-H1 on NGF effects in PC12 cells. Both necdin- and MAGE-H1-transfected cells responded to NGF by a dose-dependent increase in neurite extension, which was greater than observed in vector-transfected cells (Fig. 3A). This accelerated neurite extension was quantified in stable necdin-PC12 lines (Fig. 3B). Necdin expression levels did not change over the time course of these experiments (data not shown). No effect was observed on the number of differentiated cells. Enhanced neurite extension was not observed when BDNF was applied instead of NGF or upon application of NGF or BDNF to transfected nnr5 cells (data not shown). To establish whether the enhanced neurite outgrowth might be a consequence of accelerated differentiation, we quantified the phosphorylation levels of cdc2, a cell cycle marker (15). Phosphorylation of cdc2 was decreased ~5-fold more in necdin-PC12 cells as compared with vector-PC12 cells 24 h after NGF application (Fig. 3C), indicating that the effect of the NGF-p75-necdin signal in these cells is indeed to accelerate differentiation. Finally, we examined the subcellular distribution of necdin expression in both cycling and differentiated PC12-necdin cells. As shown in Fig. 3D necdin protein was primarily cytoplasmic in cycling PC12, and this did not change upon differentiation. An appreciable amount of necdin was found in processes and growth cones of differentiated PC12 (Fig. 3D, lower). Microscopy after harsher permeabilization or Western blot of nuclear extracts revealed lower amounts of necdin in the nucleus (data not shown). The low levels of nuclear necdin did not change after NGF stimulation or during differentiation (data not shown).


View larger version (83K):
[in this window]
[in a new window]
 
Fig. 3.   Necdin and MAGE-H1 accelerate the differentiation of PC12 cells. A, PC12 cells were transiently transfected with necdin, MAGE-H1, or vector control and incubated for 3 days in 50 ng/ml NGF. B, differentiation of two necdin-expressing stable PC12 lines, and two vector-transfected stable lines, in the presence of 50 ng/ml NGF for 2 days. Average + S.E. is shown for a representative experiment. 120-180 differentiated cells were measured for each point. C, levels of phospho-cdc2 in necdin versus vector-ransfected PC12 cells, after 24 h in 50 ng/ml NGF. Left panel shows a representative experiment, while the right panel shows average + S.E. (n = 3). D, immunofluorescence microscopy reveals predominantly cytoplasmic necdin protein in both cycling (upper) and differentiated (lower) PC12-necdin cells.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

These results establish two members of the type II MAGE gene family, necdin and MAGE-H1, as p75 interactors. Necdin and MAGE-H1 are related to NRAGE, which was previously identified as a p75 interactor (12). All three interactors contain a conserved sequence called the MAGE homology domain (MHD), a defining feature of the MAGE gene family (5). Since both necdin and MAGE-H1 are essentially comprised of only the MHD, this structural domain determines the interaction of MAGE proteins with p75. Since most type II MAGE proteins are at least as closely related in sequence to MAGE-H1 or necdin or NRAGE as the latter three are to each other (Fig. 1B), additional members of this subfamily may also associate with p75. The death domain of p75 belongs to the structurally distinct type II fold (4), and the possibility that type II MAGE proteins form a family of binding partners for type II death domain proteins is an intriguing avenue for future study. The multiplicity of potential interactions between these two families may create a compensatory network that is physiologically robust, but at the same time refractory to reductionist analysis. For example, the three MAGE interactors for p75 have overlapping expression profiles, which may complicate the analyses of null allelles for these genes, at least in the context of p75 signaling.

We examined the effects of NGF-induced p75 signaling via the two MAGE interactors in PC12 cells and found that they cause an acceleration of neuronal differentiation (Fig. 3). The p75-necdin signal must synergize with a TrkA signaling pathway, since the effects of necdin on differentiation are not seen in nnr5 cells, which lack TrkA, or upon application of BDNF to PC12 cells. Importantly, the effects of necdin on PC12 differentiation were seen only in ligand-stimulated cells and are therefore consequent to NGF signaling. Very recently published data from antisense experiments on embryonic DRG neurons also support a differentiation or survival-promoting role for necdin in NGF-responsive neurons (9). This could be due to a change in trk-p75 association (Fig. 2E), thus "freeing" TrkA from some inhibitory constraint imposed by p75, or could be due to an independent signal emanating from p75 and transduced by necdin. The propensity of necdin for homo-oligomerization (Fig. 2F), and its cytoplasmic localization in PC12 (Fig. 3D), both support the likelihood of necdin acting as a cytoplasmic adaptor for a p75-induced signaling complex. It should, however, be noted that this does not rule out a nuclear localization or role for necdin in other cell types (16).

Although these in vitro analyses suggest a role for a p75-necdin signal in neuronal differentiation, what might be the in vivo significance of such signaling? The most prominent sites of necdin expression in rodents are the DRG and hypothalamus (Fig. 1C), both of which are known to also express p75 and trk receptors. A significant (and unexplained) loss of DRG neurons has been described in p75 null mice (17), and specific hypothalamic defects have been described in one line of necdin mutant mice (18). Comparative analyses of these mutant mice may shed light on this interesting question.

To summarize, we have identified necdin and MAGE-H1 as novel interactors for the intracellular domain of p75 and suggest that type II MAGE proteins will feature prominently in p75 signal transduction.

    ACKNOWLEDGEMENTS

We are grateful to Phil Barker, Moses Chao, and Louis Reichardt for generous gifts of antisera; to Ami Aronheim for gracious help with RRS; and to R'ada Massarwa for excellent technical assistance.

    FOOTNOTES

* This work was supported by grants from the Israel Science Foundation (647/01) and the European Union Fifth Framework Program (QLRT-1999-573) (to M. F.) and by a short term European Molecular Biology fellowship (to M. T.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| Incumbent of the Daniel Koshland Sr. Career Development Chair at the Weizmann Institute of Science. To whom correspondence should be addressed. Tel.: 972-8-934-4266; Fax: 972-8-934-4112; E-mail: mike.fainzilber@weizmann.ac.il.

Published, JBC Papers in Press, October 31, 2002, DOI 10.1074/jbc.C200533200

    ABBREVIATIONS

The abbreviations used are: RRS, Ras rescue system; PMSF, phenylmethylsulfonyl fluoride; NGF, nerve growth factor; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; HA, hemagglutinin; PBS, phosphate-buffered saline; DRG, dorsal root ganglia; BDNF, brain-derived neurotrophic factor; MHD, MAGE homology domain.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Bentley, C. A., and Lee, K. F. (2000) J. Neurosci. 20, 7706-7715[Abstract/Free Full Text]
2. von Schack, D., Casademunt, E., Schweigreiter, R., Meyer, M., Bibel, M., and Dechant, G. (2001) Nat. Neurosci. 4, 977-978[CrossRef][Medline] [Order article via Infotrieve]
3. Hempstead, B. L. (2002) Curr. Opin. Neurobiol. 12, 260-267[CrossRef][Medline] [Order article via Infotrieve]
4. Liepinsh, E., Ilag, L. L., Otting, G., and Ibanez, C. F. (1997) EMBO J. 16, 4999-5005[CrossRef][Medline] [Order article via Infotrieve]
5. Barker, P. A., and Salehi, A. (2002) J. Neurosci. Res. 67, 705-712[CrossRef][Medline] [Order article via Infotrieve]
6. Broder, Y. C., Katz, S., and Aronheim, A. (1998) Curr. Biol. 8, 1121-1124[CrossRef][Medline] [Order article via Infotrieve]
7. Weskamp, G., and Reichardt, L. (1991) Neuron 6, 649-663[CrossRef][Medline] [Order article via Infotrieve]
8. Niinobe, M., Koyama, K., and Yoshikawa, K. (2000) Dev. Neurosci. 22, 310-319[CrossRef][Medline] [Order article via Infotrieve]
9. Takazaki, R., Nishimura, I., and Yoshikawa, K. (2002) Exp. Cell Res. 277, 220-232[CrossRef][Medline] [Order article via Infotrieve]
10. Clary, D. O., Weskamp, G., Austin, L. R., and Reichardt, L. F. (1994) Mol. Biol. Cell 5, 549-563[Abstract]
11. Maruyama, K., Usami, M., Aizawa, T., and Yoshikawa, K. (1991) Biochem. Biophys. Res. Commun. 178, 291-296[CrossRef][Medline] [Order article via Infotrieve]
12. Salehi, A. H., Roux, P. P., Kubu, C. J., Zeindler, C., Bhakar, A., Tannis, L. L., Verdi, J. M., and Barker, P. A. (2000) Neuron 27, 279-288[CrossRef][Medline] [Order article via Infotrieve]
13. Zhu, F., Yan, W., Zhao, Z. L., Chai, Y. B., Lu, F., Wang, Q., Peng, W. D., Yang, A. G., and Wang, C. J. (2000) BioTechniques 29, 310-313[Medline] [Order article via Infotrieve]
14. Aizawa, T., Maruyama, K., Kondo, H., and Yoshikawa, K. (1992) Brain Res. Dev. Brain Res. 68, 265-274[Medline] [Order article via Infotrieve]
15. Dobashi, Y., Shoji, M., Kitagawa, M., Noguchi, T., and Kameya, T. (2000) J. Biol. Chem. 275, 12572-12580[Abstract/Free Full Text]
16. Taniura, H., and Yoshikawa, K. (2002) J. Cell. Biochem. 84, 545-555[CrossRef][Medline] [Order article via Infotrieve]
17. Fan, G., Jaenisch, R., and Kucera, J. (1999) Neuroscience 90, 259-268[CrossRef][Medline] [Order article via Infotrieve]
18. Muscatelli, F., Abrous, D. N., Massacrier, A., Boccaccio, I., Le, Moal, M., Cau, P., and Cremer, H. (2000) Hum. Mol. Genet. 9, 3101-3110[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
J. M. Bischof, C. L. Stewart, and R. Wevrick
Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome
Hum. Mol. Genet., November 15, 2007; 16(22): 2713 - 2719.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
N. Lopez-Sanchez, Z. Gonzalez-Fernandez, M. Niinobe, K. Yoshikawa, and J. M. Frade
Single mage gene in the chicken genome encodes CMage, a protein with functional similarities to mammalian type II Mage proteins
Physiol Genomics, July 18, 2007; 30(2): 156 - 171.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Urra, C. A. Escudero, P. Ramos, F. Lisbona, E. Allende, P. Covarrubias, J. I. Parraguez, N. Zampieri, M. V. Chao, W. Annaert, et al.
TrkA Receptor Activation by Nerve Growth Factor Induces Shedding of the p75 Neurotrophin Receptor Followed by Endosomal {gamma}-Secretase-mediated Release of the p75 Intracellular Domain
J. Biol. Chem., March 9, 2007; 282(10): 7606 - 7615.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Kurita, T. Kuwajima, I. Nishimura, and K. Yoshikawa
Necdin Downregulates Cdc2 Expression to Attenuate Neuronal Apoptosis.
J. Neurosci., November 15, 2006; 26(46): 12003 - 12013.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Kuwajima, I. Nishimura, and K. Yoshikawa
Necdin promotes GABAergic neuron differentiation in cooperation with Dlx homeodomain proteins.
J. Neurosci., May 17, 2006; 26(20): 5383 - 5392.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K.-i. Kuwako, A. Hosokawa, I. Nishimura, T. Uetsuki, M. Yamada, S. Nada, M. Okada, and K. Yoshikawa
Disruption of the Paternal Necdin Gene Diminishes TrkA Signaling for Sensory Neuron Survival
J. Neurosci., July 27, 2005; 25(30): 7090 - 7099.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. A. Jungbluth, S. Ely, M. DiLiberto, R. Niesvizky, B. Williamson, D. Frosina, Y.-T. Chen, N. Bhardwaj, S. Chen-Kiang, L. J. Old, et al.
The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation
Blood, July 1, 2005; 106(1): 167 - 174.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Lee, C. L. Walker, B. Karten, S. L. Kuny, A. A. Tennese, M. A. O'Neill, and R. Wevrick
Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth
Hum. Mol. Genet., March 1, 2005; 14(5): 627 - 637.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kuwajima, H. Taniura, I. Nishimura, and K. Yoshikawa
Necdin Interacts with the Msx2 Homeodomain Protein via MAGE-D1 to Promote Myogenic Differentiation of C2C12 Cells
J. Biol. Chem., September 24, 2004; 279(39): 40484 - 40493.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. da Costa, C. McGillivray, Q. Bai, J. D. Wood, G. Evans, and K.-C. Chang
Restriction of Dietary Energy and Protein Induces Molecular Changes in Young Porcine Skeletal Muscles
J. Nutr., September 1, 2004; 134(9): 2191 - 2199.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Laduron, R. Deplus, S. Zhou, O. Kholmanskikh, D. Godelaine, C. De Smet, S. D. Hayward, F. Fuks, T. Boon, and E. De Plaen
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription
Nucleic Acids Res., August 17, 2004; 32(14): 4340 - 4350.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Gentry, N. J. Rutkoski, T. L. Burke, and B. D. Carter
A Functional Interaction between the p75 Neurotrophin Receptor Interacting Factors, TRAF6 and NRIF
J. Biol. Chem., April 16, 2004; 279(16): 16646 - 16656.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Albrecht and S. C. Froehner
DAMAGE, a Novel {alpha}-Dystrobrevin-associated MAGE Protein in Dystrophin Complexes
J. Biol. Chem., February 20, 2004; 279(8): 7014 - 7023.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-i. Kuwako, H. Taniura, and K. Yoshikawa
Necdin-related MAGE Proteins Differentially Interact with the E2F1 Transcription Factor and the p75 Neurotrophin Receptor
J. Biol. Chem., January 16, 2004; 279(3): 1703 - 1712.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
M. L. Garcia, C. S. Lobsiger, S. B. Shah, T. J. Deerinck, J. Crum, D. Young, C. M. Ward, T. O. Crawford, T. Gotow, Y. Uchiyama, et al.
NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth
J. Cell Biol., December 8, 2003; 163(5): 1011 - 1020.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. C. Kanning, M. Hudson, P. S. Amieux, J. C. Wiley, M. Bothwell, and L. C. Schecterson
Proteolytic Processing of the p75 Neurotrophin Receptor and Two Homologs Generates C-Terminal Fragments with Signaling Capability
J. Neurosci., July 2, 2003; 23(13): 5425 - 5436.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. C. Bronfman, M. Tcherpakov, T. M. Jovin, and M. Fainzilber
Ligand-Induced Internalization of the p75 Neurotrophin Receptor: A Slow Route to the Signaling Endosome
J. Neurosci., April 15, 2003; 23(8): 3209 - 3220.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/51/49101    most recent
C200533200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tcherpakov, M.
Right arrow Articles by Fainzilber, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tcherpakov, M.
Right arrow Articles by Fainzilber, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.